Page 8 - 《中国药房》2026年9期
P. 8
University Cancer Hospital, Harbin 150081, China;7. Dept. of Pharmacy, Tianjin Medical University General
Hospital, Tianjin 300052, China;8. Dept. of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan
030001, China;9. Dept. of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China;
10. Dept. of Pharmacy, Guizhou Provincial People’s Hospital, Guiyang 550002, China;11. Dept. of Pharmacy,
Qilu Hospital of Shandong University, Jinan 250012, China;12. Dept. of Pharmacy, the First Affiliated Hospital
of Xi’an Jiaotong University, Xi’an 710061, China;13. Dept. of Pharmacy, the First Affiliated Hospital of
Soochow University, Jiangsu Suzhou 215006, China;14. Dept. of Pharmacy, the First Affiliated Hospital of
Dalian Medical University, Liaoning Dalian 116011, China;15. Dept. of Pharmacy, Sichuan Academy of
Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu 610072, China; 16. Dept. of Pharmacy,
Nanjing Drum Tower Hospital, Nanjing 210009, China;17. the Third Xiangya Hospital of Central South
University, Changsha 410013, China;18. Dept. of Pharmacy, the First Affiliated Hospital of Nanchang
University, Nanchang 330006, China;19. Dept. of Pharmacy, the First Affiliated Hospital of Guangxi Medical
University, Nanning 530021, China;20. Dept. of Clinical Pharmacy, General Hospital of Northern Theater
Command, Shenyang 110016, China)
ABSTRACT OBJECTIVE To formulate Guidelines for the standardized implementation of pharmacist-managed clinics (2026
edition) in response to the challenges faced by such clinics in China, including uneven development, large discrepancies in service
specifications, insufficient patient awareness, and limited medical insurance coverage. METHODS Led by the Pharmaceutical
Affairs Professional Committee of the Chinese Hospital Association, the Evidence-based Pharmacy Professional Committee of the
Chinese Pharmaceutical Association, and the Hospital Pharmacy Professional Committee of the Cross-strait Medical and Health
Exchange Association, a total of 19 domestic hospital pharmacy experts were organized. Through a systematic review of national
policies and literature research, current practical experience was summarized. Consensus on the contents of the guidelines was
reached after in-depth discussions. RESULTS & CONCLUSIONS The guidelines covered five sections: definition and connotation
of pharmacist-managed clinics, establishment requirements, implementation and management, post competency, and practical
research. Firstly, the definition and connotation included three operational forms of pharmacist-managed clinics (independent mode,
physician-pharmacist joint mode, and online pharmacist-managed clinic mode) and classified service modes (specialty-specific,
drug-specific, and disease-specific pharmacist-managed clinics). The establishment requirements were further refined, covering
system construction (pharmaceutical service management system, quality control and assessment mechanism), personnel
qualifications (professional credentials, continuing education and professional training, etc), service recipients, as well as service
venues and facilities. Subsequently, the implementation and management of pharmacist-managed clinics were proposed, involving
service procedures, intervention measures, documentation and records, patient education and follow-up, humanistic care, as well
as risk management and quality control. Finally, post competency encompassed the competency requirements for pharmacists
providing services in pharmacist-managed clinics, as well as the suggestions on teaching methods; practical research encouraged the
conduct of high-quality pharmaceutical practice in the setting of pharmacist-managed clinics. The guidelines provide valuable guidance
for the standardized implementation of pharmacist-managed clinics in China in terms of establishment, management, teaching, and
research, fill the guideline gap in this field, and can promote the high-quality development of pharmacist-managed clinics.
KEYWORDS pharmacist-managed clinics; outpatient management; pharmacist position; guideline; standardized management
药学门诊是一种由药师提供的新兴药学服务模式, 较大,而致患者对药学门诊的认知有限、主动就诊意愿
在优化药物治疗、保障患者用药安全方面具有重要意 较低。同时,符合资质的临床药师配备数量不足以及专
义,也是医院药学高质量发展的重要组成部分。国外实 业能力有待提升,使得现有培训体系在药学门诊服务方
践经验表明,药学门诊可有效提高患者用药依从性,能 面亦有所欠缺。此外,各地药学门诊收费政策不完善、
在关注药物疗效的同时降低因药物相互作用及不良反 收费标准不统一、医保覆盖范围存在差异,也严重制约
[5]
应等引起的药源性疾病的发生率和再入院率,降低医疗 了其有序发展 。鉴于此,中国医院协会药事专业委员
[1]
费用,促进医疗资源的合理分配 。 会、中国药学会循证药学专业委员会和海峡两岸医药卫
我国药学门诊在国家相关政策的推动下取得了显 生交流协会医院药学专业委员会牵头成立指南制定工
著成效 [2―3] ,并且已有超过 17 个省级行政单位实现了药 作组,制定了《药学门诊规范化实施指南(2026 年版)》
[4]
学门诊收费 ,但目前尚处于初期探索阶段。各地区以 (以下简称“指南”),以促进我国医疗机构药学门诊的高
及各医疗机构的发展不均衡,使得服务规范与质量差异 质量发展。
· 1106 · China Pharmacy 2026 Vol. 37 No. 9 中国药房 2026年第37卷第9期

